Vitaflo signs new in-licensing agreement for Nordic countries
24-Oct-2007
"We are very pleased to see that our new subsidiary continues its strong record of signing new in-licensing agreements and expanding its portfolio. It is particularly encouraging to see that OrphaSwiss, who is already Vitaflo's partner on Naltrexone, demonstrates continued trust in Vitaflo as it's distributor in the Nordic countries", says CEO in Navamedic Øyvind W. Brekke.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.